These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16171737)

  • 1. Counseling teens and young women on Depo-Provera.
    Tonelli M; Nicoletti A
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):297-8. PubMed ID: 16171737
    [No Abstract]   [Full Text] [Related]  

  • 2. Contraceptive use in teens: a threat to bone health?
    Gold MA; Bachrach LK
    J Adolesc Health; 2004 Dec; 35(6):427-9. PubMed ID: 15581517
    [No Abstract]   [Full Text] [Related]  

  • 3. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.
    Wooltorton E
    CMAJ; 2005 Mar; 172(6):746. PubMed ID: 15743913
    [No Abstract]   [Full Text] [Related]  

  • 4. Depot-medroxyprogesterone acetate: an update.
    Bakry S; Merhi ZO; Scalise TJ; Mahmoud MS; Fadiel A; Naftolin F
    Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depo-Provera and skeletal health: reviewing the evidence; developing and disseminating a consensus.
    Guilbert ER; Kaunitz AM
    Contraception; 2009 Mar; 79(3):165-6. PubMed ID: 19185667
    [No Abstract]   [Full Text] [Related]  

  • 6. Depot medroxyprogesterone acetate: implications for weight status and bone mineral density in the adolescent female.
    Bonny AE; Harkness LS; Cromer BA
    Adolesc Med Clin; 2005 Oct; 16(3):569-84. PubMed ID: 16183540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contraception with Depo-Provera. Report of a series of 930 women].
    Mahjoub S; Lebbi I; Dakhli R; Smaïli L; Ben Hmjd R; Ben Romdhane M; Zouari F; Hamzaoui R
    Tunis Med; 2000 Nov; 78(11):662-6. PubMed ID: 11155390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.
    Cromer BA; Scholes D; Berenson A; Cundy T; Clark MK; Kaunitz AM;
    J Adolesc Health; 2006 Aug; 39(2):296-301. PubMed ID: 16857545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Black box' warning added to contraceptive injection.
    FDA Consum; 2005; 39(2):3. PubMed ID: 16124078
    [No Abstract]   [Full Text] [Related]  

  • 10. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depo-Provera dilemmas.
    Cayley J
    Br J Fam Plann; 1998 Apr; 24(1):1. PubMed ID: 9719699
    [No Abstract]   [Full Text] [Related]  

  • 12. Depo-Provera and bone density.
    Gbolade BA
    J Fam Plann Reprod Health Care; 2002 Jan; 28(1):7-11; quiz 11, 50. PubMed ID: 16259806
    [No Abstract]   [Full Text] [Related]  

  • 13. Teens and Depo-Provera: a good match?
    Contracept Technol Update; 1995 Jul; 16(7):86-8. PubMed ID: 12346507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents.
    Cromer B
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183-7. PubMed ID: 15970253
    [No Abstract]   [Full Text] [Related]  

  • 15. Depot medroxyprogesterone acetate contraceptive injections and skeletal health.
    Renner RM; Edelman AB; Kaunitz AM
    Womens Health (Lond); 2010 May; 6(3):339-42. PubMed ID: 20426597
    [No Abstract]   [Full Text] [Related]  

  • 16. Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.
    Omar H; Kives S
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183. PubMed ID: 15970252
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contraceptive injection Depo-Provera, effect on bones and teenage girls].
    Edgardh K
    Tidsskr Nor Laegeforen; 2002 Dec; 122(30):2909-11. PubMed ID: 12569721
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's responses to Depo-Provera.
    Freda MC; Abruzzo-Fogarassy M; Adams NV; Davini D; DeVore N; Merkatz IR
    MCN Am J Matern Child Nurs; 1996; 21(4):183-6. PubMed ID: 8754434
    [No Abstract]   [Full Text] [Related]  

  • 20. Spinal fracture in a young Depo-Provera user.
    Searle ES
    J Fam Plann Reprod Health Care; 2005 Jul; 31(3):255. PubMed ID: 16105313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.